Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double‐blind, randomised, placebo‐controlled, multi‐centre trial

MLA

Gorm Greisen, et al. “Re: Antenatal Magnesium Sulphate for the Prevention of Cerebral Palsy in Infants Born Preterm: A Double‐blind, Randomised, Placebo‐controlled, Multi‐centre Trial.” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 127, May 2020, pp. 1295–96. EBSCOhost, https://doi.org/10.1111/1471-0528.16268.

APA

Gorm Greisen, Christina E. Hoei-Hansen, Gija Rackauskaite, Lone Krebs, & Mads Langager Larsen. (2020). Re: Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double‐blind, randomised, placebo‐controlled, multi‐centre trial. BJOG: An International Journal of Obstetrics & Gynaecology, 127, 1295–1296. https://doi.org/10.1111/1471-0528.16268

Chicago

Gorm Greisen, Christina E. Hoei-Hansen, Gija Rackauskaite, Lone Krebs, and Mads Langager Larsen. 2020. “Re: Antenatal Magnesium Sulphate for the Prevention of Cerebral Palsy in Infants Born Preterm: A Double‐blind, Randomised, Placebo‐controlled, Multi‐centre Trial.” BJOG: An International Journal of Obstetrics & Gynaecology 127 (May): 1295–96. doi:10.1111/1471-0528.16268.